SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-043432
Filing Date
2020-04-06
Accepted
2020-04-06 09:00:19
Documents
5
Period of Report
2020-04-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014909-3_8k.htm 8-K 30116
2 EXHIBIT 3.1 tm2014909d3_ex3-1.htm EX-3.1 4021
3 EXHIBIT 16.1 tm2014909d3_ex16-1.htm EX-16.1 2751
4 EXHIBIT 99.1 tm2014909d3_ex99-1.htm EX-99.1 24843
5 GRAPHIC tm2014909d3_ex99-1img01.jpg GRAPHIC 6788
  Complete submission text file 0001104659-20-043432.txt   72679
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20775884
SIC: 2834 Pharmaceutical Preparations